Patents by Inventor Shen-Jeu Won

Shen-Jeu Won has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ursolic acid derivative and pharmaceutical composition thereof
    Patent number: 8729055
    Abstract: Several ursolic acid derivatives and pharmaceutical compositions thereof are provided. The ursolic acid derivatives and the pharmaceutical compositions thereof have at least one of an anticancer and an anti-inflammatory effects. A method for increasing a reactive oxygen species in a cell is also provided. The method comprises a step of providing the cell with a pharmaceutical composition including an ursolic acid derivative.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: May 20, 2014
    Assignee: Kaohsiung Medical University
    Inventors: Chun-Nan Lin, Huang-Yao Tu, A-Mei Huang, Bai-Luh Wei, Kim-Hong Gan, Tzyh-Chyuan Hour, Shyh-Chyun Yang, Yeong-Shiau Pu, Shen-Jeu Won
  • USE OF LEGUME EXTRACTS FOR INDUCING AND ENHANCING AUTOPHAGY AND APOPTOSIS AND FOR PREVENTING AND/OR TREATING CANCERS
    Publication number: 20120225054
    Abstract: This invention relates to a use of a fermented Glycine max (L.) extract prepared by fermenting a Glycine max (L.) extract in inducing autophagy in a subject. In particular, the fermented Glycine max (L.) extract can be used in preventing and/or treating a disease in which in a subject, such as cancer, diabetes neurodegeneration, steatohepatitis and aging. The invention also relates to a use of the fermented Glycine max (L.) extract in inducing apoptosis in combination with autophagy in a subject.
    Type: Application
    Filed: March 2, 2011
    Publication date: September 6, 2012
    Applicant: HERBAL BON BIOTECH INC.
    Inventors: FANG-NAN CHEN, SHEN-JEU WON, CHUN-LI SU
  • URSOLIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF
    Publication number: 20110190388
    Abstract: Several ursolic acid derivatives and pharmaceutical compositions thereof are provided. The ursolic acid derivatives and the pharmaceutical compositions thereof have at least one of an anticancer and an anti-inflammatory effects. A method for increasing a reactive oxygen species in a cell is also provided. The method comprises a step of providing the cell with a pharmaceutical composition including an ursolic acid derivative.
    Type: Application
    Filed: May 18, 2010
    Publication date: August 4, 2011
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Chun-Nan Lin, Huang-Yao Tu, A-Mei Huang, Bai-Luh Wei, Kim-Hong Gan, Tzyh-Chyuan Hour, Shyh-Chyun Yang, Yeong-Shiau Pu, Shen-Jeu Won
  • 1,3-Dihydroxyl-9,10-anthraquinone and 3-[(3-amino)-propoxy]- 9,10-anthraquinone derivatives and pharmaceutical compositions comprising the same
    Publication number: 20080027141
    Abstract: Disclosed herein are 1,3-dihydroxyl-9,10-anthraquinone and 3-[(3-amino)-propoxy]-9,10-anthraquinone derivatives, in particular 1,3-dihydroxy-4-prenyl-9,10-anthraquinone and 3-[3-(4-methylpiperazinyl)-propoxy]-9,10-anthraquinone, which are found to have inhibitory activities against several types of human tumor/cancer cells and thus can be used in the manufacture of pharmaceutical compositions for use in the treatment of tumors/cancers.
    Type: Application
    Filed: July 5, 2006
    Publication date: January 31, 2008
    Applicant: Kaohsiung Medical University
    Inventors: Chun-Nan Lin, Shen-Jeu Won, Chi-Hung Teng
  • Compounds for the treatment of hepatoma
    Patent number: 5981774
    Abstract: Compounds of general Formula I in which the substituents of R.sub.1 -R.sub.7 are hydrogen, hydroxy group, C.sub.1-6 alkyl group, C.sub.1-6 alkoxy group, or epoxypropoxy, but at the most, six of the substituents can simultaneously be hydrogen, methoxy group, or hydroxy group, or epoxypropoxy group for activity against hepatoma. There are also described processes for the preparation of the novel compounds and useful intermediates. Substitute benzophenones are described.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: November 9, 1999
    Assignee: National Science Council
    Inventors: Chun-Nan Lin, Shen-Jeu Won, Hsiao-Sheng Liu, Shorong-Shii Liou
  • Compounds for the treatment of hepatoma
    Patent number: 5741813
    Abstract: Compounds of general Formula I in which the substituents of R.sub.1 -R.sub.7 are hydrogen, hydroxy group, C.sub.1-6 alkyl group, C.sub.1-6 alkoxy group, or epoxypropoxy, but at the most, six of the substituents can simultaneously be hydrogen, methoxy group, or hydroxy group, or epoxypropoxy group for activity against hepatoma. There are also described processes for the preparation of the novel compounds and useful intermediates. Substitute benzophenones are described.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: April 21, 1998
    Assignee: National Science Council
    Inventors: Chun-Nan Lin, Shen-Jeu Won, Hsiao-Sheng Lieu, Shorong-Shii Liou